TXG: UBS Raises Price Target for 10x Genomics to $20

Endpoints NewsIndustry seeks more clarity on commissioner's voucher program

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-June 4, 2026

BioWorldBioWorld and Nasdaq stock indices

Endpoints NewsHouse committee directs FDA to speed up IND sign-off process

FierceBiotechExecutive Interviews at Fierce Biotech Week 2026

BioWorldBiopharma money raised by month in 2026 (US$M)

BioPharma DiveStudy data convince Lundbeck to push new migraine drug forward

BioPharma DiveGeneric drugmakers gain key victory in ‘skinny label’ patent case

Endpoints NewsInnovent declares Phase 3 success for ADC that attracted huge Takeda deal

FierceBiotechAffibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection

Clinical OMICsInfluenza Drugs Could Prevent Cognitive Decline in Chronic Viral Infections